CN101057677A - 新禧营养素增补剂 - Google Patents
新禧营养素增补剂 Download PDFInfo
- Publication number
- CN101057677A CN101057677A CNA2007100975321A CN200710097532A CN101057677A CN 101057677 A CN101057677 A CN 101057677A CN A2007100975321 A CNA2007100975321 A CN A2007100975321A CN 200710097532 A CN200710097532 A CN 200710097532A CN 101057677 A CN101057677 A CN 101057677A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- zinc
- xinxi
- nutrient
- capsules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims description 23
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 71
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 50
- 239000011701 zinc Substances 0.000 claims abstract description 41
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 40
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 23
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 23
- 239000011718 vitamin C Substances 0.000 claims abstract description 23
- 239000002775 capsule Substances 0.000 claims abstract description 20
- 239000000843 powder Substances 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims abstract description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 31
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 29
- 239000011669 selenium Substances 0.000 claims description 18
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 16
- 229910052711 selenium Inorganic materials 0.000 claims description 16
- 229940091258 selenium supplement Drugs 0.000 claims description 16
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 15
- 229930003427 Vitamin E Natural products 0.000 claims description 15
- 235000019152 folic acid Nutrition 0.000 claims description 15
- 239000011724 folic acid Substances 0.000 claims description 15
- 229960000304 folic acid Drugs 0.000 claims description 15
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 15
- 235000019165 vitamin E Nutrition 0.000 claims description 15
- 229940046009 vitamin E Drugs 0.000 claims description 15
- 239000011709 vitamin E Substances 0.000 claims description 15
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical group [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 12
- 239000011746 zinc citrate Substances 0.000 claims description 12
- 235000006076 zinc citrate Nutrition 0.000 claims description 12
- 229940068475 zinc citrate Drugs 0.000 claims description 12
- MKWYFZFMAMBPQK-UHFFFAOYSA-J sodium feredetate Chemical group [Na+].[Fe+3].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O MKWYFZFMAMBPQK-UHFFFAOYSA-J 0.000 claims description 9
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 8
- 229940088594 vitamin Drugs 0.000 claims description 8
- 229930003231 vitamin Natural products 0.000 claims description 8
- 235000013343 vitamin Nutrition 0.000 claims description 8
- 239000011782 vitamin Substances 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 4
- 239000011670 zinc gluconate Substances 0.000 claims description 4
- 235000011478 zinc gluconate Nutrition 0.000 claims description 4
- 229960000306 zinc gluconate Drugs 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 3
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 3
- 239000011781 sodium selenite Substances 0.000 claims description 3
- 235000015921 sodium selenite Nutrition 0.000 claims description 3
- 229960001471 sodium selenite Drugs 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 229940104757 vitamin E 50 mg Drugs 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 16
- 239000000470 constituent Substances 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 32
- 229910052742 iron Inorganic materials 0.000 description 15
- 235000016709 nutrition Nutrition 0.000 description 15
- 230000000694 effects Effects 0.000 description 12
- 230000035764 nutrition Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 7
- 210000003754 fetus Anatomy 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000035935 pregnancy Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000001568 sexual effect Effects 0.000 description 5
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 230000008485 antagonism Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000035558 fertility Effects 0.000 description 3
- 201000007094 prostatitis Diseases 0.000 description 3
- 230000019100 sperm motility Effects 0.000 description 3
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 description 2
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 210000001198 duodenum Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000004225 ferrous lactate Substances 0.000 description 2
- 235000013925 ferrous lactate Nutrition 0.000 description 2
- 229940037907 ferrous lactate Drugs 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 229960003284 iron Drugs 0.000 description 2
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011576 zinc lactate Substances 0.000 description 2
- 235000000193 zinc lactate Nutrition 0.000 description 2
- 229940050168 zinc lactate Drugs 0.000 description 2
- FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 description 1
- KWJPTZSGVFKSDH-UHFFFAOYSA-N 1-(3-nitrophenyl)piperazine;dihydrochloride Chemical compound Cl.Cl.[O-][N+](=O)C1=CC=CC(N2CCNCC2)=C1 KWJPTZSGVFKSDH-UHFFFAOYSA-N 0.000 description 1
- GIPOFCXYHMWROH-UHFFFAOYSA-L 2-aminoacetate;iron(2+) Chemical compound [Fe+2].NCC([O-])=O.NCC([O-])=O GIPOFCXYHMWROH-UHFFFAOYSA-L 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000005955 Ferric phosphate Substances 0.000 description 1
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 1
- 206010021929 Infertility male Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- JPIJQSOTBSSVTP-STHAYSLISA-N L-threonic acid Chemical compound OC[C@H](O)[C@@H](O)C(O)=O JPIJQSOTBSSVTP-STHAYSLISA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 102000008114 Selenoproteins Human genes 0.000 description 1
- 108010074686 Selenoproteins Proteins 0.000 description 1
- YKXCYTXGDOCHSX-UHFFFAOYSA-N [Zn].CC1=NC=CC=C1 Chemical compound [Zn].CC1=NC=CC=C1 YKXCYTXGDOCHSX-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- MCDLETWIOVSGJT-UHFFFAOYSA-N acetic acid;iron Chemical compound [Fe].CC(O)=O.CC(O)=O MCDLETWIOVSGJT-UHFFFAOYSA-N 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- MDXRFOWKIZPNTA-UHFFFAOYSA-L butanedioate;iron(2+) Chemical compound [Fe+2].[O-]C(=O)CCC([O-])=O MDXRFOWKIZPNTA-UHFFFAOYSA-L 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 235000010376 calcium ascorbate Nutrition 0.000 description 1
- 229940047036 calcium ascorbate Drugs 0.000 description 1
- 239000011692 calcium ascorbate Substances 0.000 description 1
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 229960002413 ferric citrate Drugs 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- 229940032958 ferric phosphate Drugs 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- 239000011645 ferric sodium diphosphate Substances 0.000 description 1
- 235000019851 ferric sodium diphosphate Nutrition 0.000 description 1
- 229960001459 ferrous ascorbate Drugs 0.000 description 1
- 229940086413 ferrous bisglycinate Drugs 0.000 description 1
- 239000011640 ferrous citrate Substances 0.000 description 1
- 235000019850 ferrous citrate Nutrition 0.000 description 1
- 239000011773 ferrous fumarate Substances 0.000 description 1
- 235000002332 ferrous fumarate Nutrition 0.000 description 1
- 229960000225 ferrous fumarate Drugs 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 229960001604 ferrous succinate Drugs 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 229940070818 glycyrrhizate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- WBJZTOZJJYAKHQ-UHFFFAOYSA-K iron(3+) phosphate Chemical compound [Fe+3].[O-]P([O-])([O-])=O WBJZTOZJJYAKHQ-UHFFFAOYSA-K 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229910000399 iron(III) phosphate Inorganic materials 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 229940056902 l- threonic acid Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 1
- 229940055619 selenocysteine Drugs 0.000 description 1
- 235000016491 selenocysteine Nutrition 0.000 description 1
- 150000003346 selenoethers Chemical class 0.000 description 1
- 230000009329 sexual behaviour Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- AEDLILNWEXDEHC-UHFFFAOYSA-M sodium;butanedioic acid;3-carboxy-3,5-dihydroxy-5-oxopentanoate Chemical compound [Na+].OC(=O)CCC(O)=O.OC(=O)CC(O)(C(O)=O)CC([O-])=O AEDLILNWEXDEHC-UHFFFAOYSA-M 0.000 description 1
- XWQGIDJIEPIQBD-UHFFFAOYSA-J sodium;iron(3+);phosphonato phosphate Chemical compound [Na+].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O XWQGIDJIEPIQBD-UHFFFAOYSA-J 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 229960000314 zinc acetate Drugs 0.000 description 1
- 229940110280 zinc methionine Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- CNMFGFBWPBBGKX-SCGRZTRASA-L zinc;(2s)-2-amino-4-methylsulfanylbutanoate Chemical compound [Zn+2].CSCC[C@H](N)C([O-])=O.CSCC[C@H](N)C([O-])=O CNMFGFBWPBBGKX-SCGRZTRASA-L 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种新禧营养素增补剂，是新婚蜜月时期青年男女专用的含微量元素和维生素的营养素增补剂，属于保健食品领域。本发明的营养素增补剂其形态可以为片剂、胶囊、粉剂、口服液等各种形态使用，还可以分为新郎(男士)专用型和新娘(女士)专用型两种，其必要条件是产品配方中必须含有锌元素和维生素C，且每种形态的最小剂量含有锌元素2.5～25mg，维生素C 25～500mg。本发明配比合理，针对性强，协同增效作用显著，易于生产，服用方便。
Description
技术领域
本发明涉及一种微量元素和维生素的营养素增补剂，更具体地说是一种新婚蜜月时期青年男女专用的新禧营养素增补剂，属于保健食品领域。
背景技术
新婚是青年男女人生中最响亮的乐章，随之相伴而来的是小生命的诞生，这将给家庭生活增添无限的欢乐和幸福。然而，新婚燕尔感情灼热，往往只重视两性的欢快，以致性生活频繁，加之忙于走亲访友，外出旅游，操办婚事等劳累后饮食简单，营养跟不上，结果入不敷出，影响健康，身体受损。频繁的性生活会使男子感到疲劳，甚至出现食欲不振，精神恍惚，阳痿，早泄等性能力下降。在这种营养供不应求的情况下，精子的活力和精子、卵子的质量都会降低，此时女方怀孕对胎儿来说是十分不利的。有针对性的补充合理的营养，有利于保障高质量的精子、卵子结合发育成健康的胎儿，是优生优育的先决条件，同时对新婚夫妇婚后性生活的和谐提供了物质基础。尤其是结婚后未采取避孕措施，希望尽快有一个宝宝的夫妇，合理的营养就更为重要。
目前国内外市场上，各种营养素补充剂琳琅满目，层出不穷。主要有单一补钙、补铁、补锌、补维生素的单体制剂，及补充多种矿物质和维生素的“21金维他”、“黄金搭档”、“金施尔康”、“善存片”等复合制剂，但是没有专门针对新婚青年男女所用的营养增补剂。虽然有按年龄阶段划分或按男士、女士来分所开发的营养素补充剂类保健食品，但是配方均不够合理，主要表现为营养素的补充品种和数量要么过多，使一些不缺乏的营养素过剩；要么过少，使真正缺乏的营养素达不到合理地补充量，起不到新婚时期的特定营养需求和保健效果。同时还存在营养素间的搭配缺少或不符合人体需要的合理比例关系，不能起到营养素之间的协同增效的效果，反而还会产生营养素间的相互拮抗，以致造成身体健康方面的危害。由于不同配方的产品，其作用和效果是不同的，因而需要研究出符合新婚时期青年男女人体生理特殊的营养需求，具有针对性强并取得良好营养补充效果的营养素增补剂产品。
发明内容
针对以上问题，本着合理营养，协同增效的原则，本发明人经过细致的调查和全面审慎的研究，在研究中发现新婚前后时期青年男女最容易缺乏和最需要的营养素是锌和维生素C，进一步研究并发现了符合下述目的的营养组合物，从而完成了本发明。
本发明的目的之一，就在于提供一种特别适合青年男女在新婚蜜月时期补充营养素的新型营养素增补剂；
本发明的目的之二，就在于有针对性的补充新婚男士所需要的营养素，促进精子的健康发育，保障精子的活力和数量，预防和减少前列腺炎症等疾病；
本发明的目的之三，就在于有针对性的补充新婚女士所需要的营养素，做好怀孕前后优生优育的营养准备，预防由于营养缺乏而对新婚女性健康的危害。
本发明的主要技术方案，是按照发明人多年的从业研究实践，参照中国营养学会颁布的《中国居民膳食营养素摄入量标准(DRIs)》和营养调查的结果，专门为新婚蜜月时期的青年男女补充所需营养，经过精确筛选确定本发明的维生素和微量元素的种类和剂量。
本发明的营养素增补剂其形态可以为片剂、胶囊、粉剂、口服液等各种形态使用，可以是任何可以服用的剂型，其必要条件是产品配方中必须含有锌元素和维生素C，且每种形态的最小剂量含有锌元素(Zn)2.5～25mg，维生素C25～500mg。所述的最小剂量是指制剂的单位，如片剂的每片，胶囊的每粒胶囊等。根据性别来分，本发明的营养素增补剂还可以分为新郎(男士)专用型和新娘(女士)专用型两种。其中新郎专用型的产品配方中还可以含有或不含有硒元素(Se)、维生素E；新娘专用型的产品配方中还可以含有或不含有铁元素(Fe)、叶酸和维生素E，如果含有铁元素，则还需要满足铁元素和维生素C的比例为1∶5～25，更进一步优选为1∶5～10，铁和锌的比例为1～2∶1。本发明的各产品形态的最小包装剂量的具体配方从下表可以很直观的看出，其中未包含各种形态的药剂学上可接受的各种辅料的含量。
新禧营养增补剂营养成分配方表
| 营养素名称 | 营养素含量(最小包装剂量，mg) | |
| 新郎(男士)专用型 | 新娘(女士)专用型 | |
| 锌(Zn) | 2.5～25 | 2.5～25 |
| 铁(Fe) | 0 | 0～25 |
| 硒(Se) | 0～0.1 | 0 |
| 维生素C | 25～500 | 25～500 |
| 维生素E | 0～150 | 0～150 |
| 叶酸 | 0 | 0～0.4 |
本发明所述的营养增补剂是利用现有的保健食品或药物成型工艺，加入或不加入辅料来实现的，其制备工艺并无特别的限定。
本发明的技术方案中，维生素C的来源是指L-抗坏血酸、抗坏血酸钙中的一种或两种；维生素E的来源是指D-α-生育酚及其醋酸酯类；叶酸的来源是指蝶酰谷氨酸(叶酸)；
锌元素的来源是指柠檬酸锌、乳酸锌、葡萄糖酸锌、甘氨酸锌、醋酸锌、蛋氨酸锌、甘草酸锌、甲基吡啶锌、氧化锌、硫酸锌、酵母锌的一种或几种，更为优选的柠檬酸锌，这是因为柠檬酸锌口感好，含锌量高，无不良气味和涩味，为稳定的络合物结构，无胃肠道刺激。柠檬酸锌是锌与柠檬酸的小分子配合物，可避免与铁发生拮抗作用，同时可拮抗环境中铅、镉等重金属对人体的危害。柠檬酸锌是人体母乳中锌的一种主要形式，具有重要的免疫功能；同时还是人体前列腺和精液中锌的主要存在形式，具有改善生育能力等功能。
硒元素的来源是指抗坏血酸硒、硒化卡拉胶、半胱氨酸硒、硒蛋白、亚硒酸钠、硒酵母中的一种或几种；
铁元素的来源是指磷酸铁、焦磷酸铁、焦磷酸铁钠、乳酸亚铁、葡萄糖酸亚铁、琥珀酸亚铁、富马酸亚铁、柠檬酸亚铁、柠檬酸铁铵、琥珀酸柠檬酸铁钠、柠檬酸铁、抗坏血酸亚铁、L-苏糖酸亚铁、天门冬氨酸亚铁、醋酸亚铁、甘氨酸亚铁、甘氨酸铁、乙二胺四乙酸铁钠、血红素铁等的一种或几种，更为优选的是乙二胺四乙酸铁钠，这是因为乙二胺四乙酸铁钠为稳定的螯合物，无胃肠刺激，有特异的十二指肠吸收。其在胃中结合紧密，进入十二指肠后，铁才被释放和吸收。乙二胺四乙酸铁钠的吸收率高，能避免植酸等对铁剂吸收的阻碍，研究表明其铁的吸收率为硫酸亚铁的2～3倍。乙二胺四乙酸铁钠安全无毒副作用，属实际无毒物，被列为“一般认为安全”(GRAS)。在吸收过程中EDTA还可与有害元素结合迅速排泄而起到解毒剂的作用。乙二胺四乙酸铁钠具有促进膳食中其他铁源或内源性铁源吸收的作用，同时还可促进锌的吸收，而对钙的吸收无影响。
本发明的优点和有益效果在于：
1.本发明中的锌元素和维生素C科学配比组合，能够有效地提高青年男女的机体免疫力，尤其是维生素C可以促进锌元素的吸收，锌也可以使维生素C的吸收和在体内的利用时间延长，起到缓释利用的效果。两者都是维持优质的婚姻生活、优生优育、促进胎儿正常发育的重要营养素，而且是新婚时期最易缺乏的营养素。锌在维持和助长性机能，提高精子数量方面起着重要作用。对于吸烟、饮酒的新婚夫妇来说，本发明的营养增补剂可以减轻烟、酒对身体的危害。这是因为吸烟会消耗大量的维生素C，吸一支烟可以消耗破坏掉25～100mg的维生素C，而且可以补充因酒精而引起的体内锌元素的排泄和流失。
2.本发明中的新郎(男士)专用型营养增补剂中，选择性的加入硒元素和维生素E，但不是必须加入硒元素和维生素E，其原因为硒元素与锌元素一样，也是精液的组成物质，对激发精子活力，预防男性不孕症有功效。但一般来说硒元素除贫硒地区外不易缺乏，且硒元素的需要量甚微，中毒剂量和安全剂量相差很近，除特殊目的或有缺乏症状时，一般不宜补充。维生素E具有调节性腺的功能，可使体内雄性激素水平提高，并有增强精子活力的作用，但是维生素E在食物中的分布甚广，来源充足，通常膳食中不易造成缺乏。所以本发明中只是选择性的加入，从而避免不负责任的滥施强化与增补。在新郎专用型产品中不加入铁元素，是因为男士一般不会缺铁。选择性加入硒元素和维生素E后，锌元素、维生素C、维生素E、硒元素四者组合，尤其是对性行为频繁、生育力低下、或有前列腺炎症的男士更为有益。
3.本发明中的新娘(女士)专用型营养增补剂中选择性加入了铁、叶酸和维生素E。铁的缺乏可导致女性性交后出现疲乏、无力、气喘、面色苍白等现象，还可以避免女性出现缺铁性贫血。在本发明中还特别注意铁和锌、铁和维生素C的比例，合理的维生素C可以促进铁和锌的吸收，避免铁和锌之间的拮抗。维生素E可以使体内雌性激素浓度提高，提高生育能力，预防怀孕后的流产、早产等。另外，叶酸和锌元素之间的关系也很密切，锌元素有助于叶酸的吸收，叶酸可以预防怀孕后出现神经管畸形胎儿的发生。锌、铁、维生素C、维生素E、叶酸五者组合，尤其是在“坐床喜”观念影响下，对新婚蜜月期希望怀孕的女性更为有益。
4.本发明的营养素增补剂配比合理，针对性更强，协同增效作用显著，且易于生产，服用方便，可以满足新婚蜜月期青年男女的营养需要，并可间接作用于胎儿，确保胎儿的健康生长和发育，是一种良好的新型营养素增补剂。从结婚前三个月开始直至怀孕后，正常食用，不会给身体带来危害和副作用。本发明还会有效提高人体的自身免疫力，可抗氧化，预防感冒，促进伤口愈合和胶原蛋白的形成，使皮肤光滑、美白、有弹性，使新婚夫妇更加健美。
下面结合具体实施例对本发明作进一步的说明，但是不应理解是对本发明的限制。
具体实施例
实施例1：准确称取柠檬酸锌50g、维生素C200g，将两者充分混合均匀后装入空胶囊中，每粒胶囊0.25g，共得胶囊1000粒，相当于每粒胶囊含锌元素15mg，维生素C200mg。
该胶囊可以供新婚夫妇同时食用，经21对年龄在21～37岁之间的新婚夫妇坚持服用一段时间后，均反映蜜月期间疲劳感减轻，没有出现气短心虚、恍惚如梦等症状，而且都觉得精神充沛，身体舒爽，幸福感倍增。其中有6人患有痤疮，坚持服用了3个月后，有5人基本痊愈。有1人属于再婚的男士，年龄28岁，婚史1年半，抽烟和喝酒均较多，脸色发黄发暗，一直没有小孩，经医院检查，该男士精子密度很低，且精子活力不高，导致家庭不和睦，感情破裂而离婚，在第二次婚姻开始前3个月开始服用本胶囊，服用后面色比以前明显改善，精子的活力和数量显著增加，更为奇迹的是，再婚4个月后妻子怀孕了，目前小宝宝健康可爱。
实施例2：新郎(男士)专用型
准确称取柠檬酸锌20g、葡萄糖酸锌20g、维生素C150g、亚硒酸钠0.11g、维生素E醋酸酯干粉(50％)100g，加入可直接压片淀粉159.89g，充分混合均匀后压成片剂1000片，每片0.45g，相当于每片含锌元素9mg，维生素C150mg，硒元素50μg，维生素E50mg。
该片剂为新郎(男士)专用型，经45名男士服用后均反映效果良好，其中有3名经医院检查患有泌尿系统感染，2名患有前列腺炎症，食用本品后均症状减轻。
实施例3：新娘(女士)专用型
准确称取柠檬酸锌25g、维生素C125g、乙二胺四乙酸铁钠100g、叶酸0.4g、维生素E醋酸酯干粉(50％)49.6g，充分混合均匀后制成1000粒胶囊，每粒0.3g，相当于每粒胶囊含锌元素7.5mg，维生素C125mg，铁元素13mg，叶酸400μg，维生素E24.8mg。
该胶囊为新娘(女士)专用型，经33名女性服用后均反映效果良好，其中有5名经医院检查患有贫血，食用该产品后好转；2名患有严重脱发，食用本品症状减轻。食用本品3个月以后怀孕的6例女性，无一流产。本发明的产品易于吸收，作用优良，营养成分相互配比，相辅相成，获得了良好的效果。
实施例4：新郎(男士)专用型
准确称取乳酸锌50g、维生素C100g、维生素E醋酸酯干粉(50％)40g，糊精110g，充分混合均匀后制成1000粒胶囊，每粒0.4g，相当于每粒胶囊含锌元素11mg，维生素C100mg，维生素E20mg。
实施例5：新娘(女士)专用型
准确称取葡萄糖酸锌40g、乳酸亚铁55g、维生素C120g、乳糖75g、淀粉210g，充分混合均匀后压成片剂1000片，每片0.5g，相当于每片含锌元素5.2mg，维生素C120mg，铁元素10.4mg。
Claims (9)
1.一种新禧营养素增补剂，其特征在于其形态是经加工制成的片剂、冲剂、胶囊、口服液，每种形态的最小剂量含有锌元素2.5～25mg，维生素C25～500mg。
2.如权利要求1所述的一种新禧营养素增补剂，其特征在于分为新郎专用型和新娘专用型两种。
3.如权利要求1、2所述的一种新禧营养素增补剂，其特征在于新郎专用型的各形态最小剂量含有锌元素2.5～25mg，维生素C25～500mg，硒元素0～0.1mg，维生素E0～150mg。
4.如权利要求1、2所述的一种新禧营养素增补剂，其特征在于新娘专用型的各形态最小剂量含有锌元素2.5～25mg，维生素C25～500mg，铁元素0～25mg，维生素E0～150mg，叶酸0～0.4mg。
5.如权利要求1-4所述的一种新禧营养素增补剂，其特征在于锌元素的来源为柠檬酸锌。
6.如权利要求2、4所述的一种新禧营养素增补剂，其特征在于铁元素的来源为乙二胺四乙酸铁钠。
7.如权利要求1所述的一种新禧营养素增补剂，其特征在于准确称取柠檬酸锌50g、维生素C200g，将两者充分混合均匀后装入空胶囊中，每粒胶囊0.25g，共得胶囊1000粒，相当于每粒胶囊含锌元素15mg，维生素C200mg。
8.如权利要求1-3所述的一种新禧营养素增补剂，其特征在于准确称取柠檬酸锌20g、葡萄糖酸锌20g、维生素C150g、亚硒酸钠0.11g、维生素E醋酸酯干粉(50％)100g，加入可直接压片淀粉159.89g，充分混合均匀后压成片剂1000片，每片0.45g，相当于每片含锌元素9mg，维生素C150mg，硒元素50μg，维生素E50mg。
9.如权利要求1、2、4所述的一种新禧营养素增补剂，其特征在于准确称取柠檬酸锌25g、维生素C125g、乙二胺四乙酸铁钠100g、叶酸0.4g、维生素E醋酸酯干粉(50％)49.6g，充分混合均匀后制成1000粒胶囊，每粒0.3g，相当于每粒胶囊含锌元素7.5mg，维生素C125mg，铁元素13mg，叶酸400μg，维生素E24.8mg。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100975321A CN101057677B (zh) | 2007-04-27 | 2007-04-27 | 新禧营养素增补剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100975321A CN101057677B (zh) | 2007-04-27 | 2007-04-27 | 新禧营养素增补剂 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101057677A true CN101057677A (zh) | 2007-10-24 |
| CN101057677B CN101057677B (zh) | 2010-09-22 |
Family
ID=38864098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007100975321A Active CN101057677B (zh) | 2007-04-27 | 2007-04-27 | 新禧营养素增补剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101057677B (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT13384U1 (de) * | 2012-12-14 | 2013-11-15 | Fritsch Florian Mag | Nahrungsergänzungsmittel |
| CN106074598A (zh) * | 2016-06-14 | 2016-11-09 | 奥格生物技术（六安）有限公司 | 一种治疗精液异常男性不育症的复方有机螯合微量元素组合物及其制备方法 |
| CN107536055A (zh) * | 2017-10-19 | 2018-01-05 | 杭州鑫伟低碳技术研发有限公司 | 一种辅助治疗不孕不育的雨生红球藻虾青素产品配方 |
| CN108669403A (zh) * | 2018-05-28 | 2018-10-19 | 广州富诺营养科技有限公司 | 一种含铁锌钙多种维生素的泡腾片及其环形制剂与制备方法 |
-
2007
- 2007-04-27 CN CN2007100975321A patent/CN101057677B/zh active Active
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT13384U1 (de) * | 2012-12-14 | 2013-11-15 | Fritsch Florian Mag | Nahrungsergänzungsmittel |
| CN106074598A (zh) * | 2016-06-14 | 2016-11-09 | 奥格生物技术（六安）有限公司 | 一种治疗精液异常男性不育症的复方有机螯合微量元素组合物及其制备方法 |
| CN107536055A (zh) * | 2017-10-19 | 2018-01-05 | 杭州鑫伟低碳技术研发有限公司 | 一种辅助治疗不孕不育的雨生红球藻虾青素产品配方 |
| CN108669403A (zh) * | 2018-05-28 | 2018-10-19 | 广州富诺营养科技有限公司 | 一种含铁锌钙多种维生素的泡腾片及其环形制剂与制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101057677B (zh) | 2010-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200812503A (en) | Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass | |
| DiSilvestro | Handbook of minerals as nutritional supplements | |
| Remedios et al. | Bariatric nutrition guidelines for the Indian population | |
| JPH06504259A (ja) | 高コレステロール血症および細胞過増殖性障害の予防および処置用処方および方法 | |
| JPH10174565A (ja) | 高い生物学的利用能をもつ鉄‐カルシウムミネラル補給物 | |
| CN108157953A (zh) | 一种全营养配方食品及其制备方法 | |
| US20240122935A1 (en) | Maternal vitamin b2 administration for the prevention of increased adiposity, overweight or obesity in the offspring | |
| CN101057677B (zh) | 新禧营养素增补剂 | |
| Di Matola et al. | Thyroid dysfunction following a kelp-containing marketed diet | |
| CN106135791A (zh) | 一种强化营养的降糖特膳即食谷物粉 | |
| US9327001B2 (en) | Nutritional supplement for weight management | |
| MXPA05010930A (es) | Suplemento multivitaminico y mineral para mujeres embarazadas. | |
| JP2022095632A (ja) | 組織中の正常値を超える数の顆粒球に関連する障害の治療又は予防において使用するためのカカオポリフェノール及び可溶性食物繊維 | |
| Merrell | The importance of minerals in the long term health of humans | |
| Dowd | Role of calcium, vitamin D, and other essential nutrients in the prevention and treatment of osteoporosis | |
| Adu‐Afarwuah | Impact of nutrient supplementation on maternal nutrition and child growth and development in Sub‐Saharan Africa: the case of small‐quantity lipid‐based nutrient supplements | |
| US11065271B2 (en) | Maternal vitamin B12 administration for the prevention of increased adiposity, overweight or obesity in the offspring especially offspring overweight and/or obese mothers | |
| CN102578572A (zh) | 一种矿物质及维生素营养补充剂 | |
| SG188628A1 (en) | Trivalent chromium and boron fortifying composition, a hydration supplement, and process for preparing the same | |
| Dhodapkar et al. | COMPOSITE DIETARY MANAGEMENT WITH AGNI CHIKITSA IN MALNOURISHED CHILD-CASE STUDY | |
| Vir et al. | Iron deficiency and iron deficiency anemia in young children | |
| Kesavan et al. | Efficacy of Oral Protein Supplementation “PRO 360 Diabetic” on Diabetic Foot Ulcer Patients-A Pilot study | |
| Sazawal et al. | Zinc—an essential micronutrient for health and development | |
| Holt | Part 1: Viagra Versus a Natural Approach | |
| Case | The vitamin cure for women's health problems |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200114 Address after: 021008 the Inner Mongolia Autonomous Region Hulun Buir city Hailar District Office of Jiagedaqi Hulun Road No. 67 Patentee after: Hulun Buir dairy Dairy Co., Ltd. Address before: 050031 Hebei Province, Shijiazhuang city Yuhua District No. 262 South Main Street Sports Fujin building block B room 1-1101 Patentee before: Li Weiping |
|
| TR01 | Transfer of patent right |